Safety, pharmacokinetic and pharmacodynamic evaluation of CTP-543 (deuterated ruxolitinib) in a phase I healthy volunteer study

von Hehn, J; Hamilton, C; Uttamsingh, V; Hogan, K; Aslanian, AM; Grotbeck, B; Brummel, CL; Braman, V; Cassella, J

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017; 76 (6): AB225